Hong Kong stocks with biopharmaceutical concepts led the decline in early trading, with Rongchang Biopharma (09995.HK) falling more than 5%, WuXi Biologics (02268.HK) and WuXi Biologics (02269.HK) both falling more than 4%, and InnoCare Pharma (09969.HK), WuXi AppTec (02359.HK) and other stocks following the decline; on the news front, the U.S. "Big Beautiful Act" was passed early this morning, the bill proposes to cut healthcare spending.

2025-07-07 10:14:48

WuXi Biologics WuXi AppTec

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Oppenheimer: Raises Nvidia (NVDA.O) price target from $175 to $200.
                            2025-07-15

                                    Shanghai: Accelerate the implementation of major engineering projects and build core capabilities of the smart glasses industry
                            2025-07-15

                                    ETF Midday Review: ChiNext Artificial Intelligence ETF Southern led the gains by 4.95%, while the CSI 2000 ETF Fund led the losses by 4.36%
                            2025-07-15

                                    Tesla Model Y long-range rear-wheel drive version is priced at about RMB 567,000 in India
                            2025-07-15

                                    BOE A: Will submit a review to the ITC regarding the preliminary ruling of the 337 investigation on trade secrets
                            2025-07-15